Latest in News & Research

Psoriatic Arthritis May Up Risk for Preterm Birth, C-Section

Risk for preterm birth increased with antirheumatic treatment for psoriatic arthritis -- particularly biologics -- during pregnancy

By Physician’s Briefing Staff | | October 20, 2021

FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases

Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis

By Physician’s Briefing Staff | | October 19, 2021

Skin Cancer App Fails to Identify Rare, Aggressive Cancers

Sensitivity and specificity for detecting Merkel cell carcinoma and amelanotic melanoma was 79.4 and 37.7 percent, respectively

By Physician’s Briefing Staff | | October 14, 2021

Nonmelanoma Skin Cancers Larger Among Hispanic Patients

Mohs micrographic surgery defect sizes larger for Hispanic/Latino patients than for non-Hispanic White patients

By Physician’s Briefing Staff | | October 14, 2021

FDA Warns Against Using At-Home Dermal Filler 'Pens'

Serious adverse events have been reported in connection with dermal filler use, such as permanent damage to the skin, lips, and eyes

By Robert Preidt and Ernie Mundell (HealthDay News) | | October 14, 2021

What Predictors Differentiate ISK From SCC?

Dotted vessels, branched linear vessels, white structureless areas, white circle surrounding follicles predict SCC

By Dermsquared Editorial Team | | October 13, 2021

Does Abatacept Cut Psoriasis Relapse After Ustekinumab Withdrawal?

Similar proportion of patients who switched to abatacept and who continued ustekinumab had psoriasis relapse between weeks 12 and 88

By Dermsquared Editorial Team | | October 13, 2021

Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis

Differential risk for serious infection or respiratory tract infection, including SARS-CoV-2, not seen among biologics used to treat psoriasis

By Physician's Briefing Staff | | October 08, 2021

No Causal Relationship Seen Between Allergic Disease, Mental Health

Mendelian randomization did not show evidence of causal effects between genetic risk for allergic disease and self-reported mental health

By Physician’s Briefing Staff | | October 07, 2021

COVID-19 Vaccine Concerns ID'd in Psoriasis, Psoriatic Arthritis Patients

Patient hesitancy stems from concerns about the safety of the vaccine and whether the vaccine would aggravate their underlying condition

By Physician’s Briefing Staff | | October 07, 2021

How Does Secukinumab Measure Up for Pediatric Patients With Plaque Psoriasis?

Both low and high secukinumab doses superior to historical placebo for PASI75/PASI90 and IGA0/1

By Dermsquared Editorial Team | | October 06, 2021

What Is the Efficacy of Ruxolitinib Versus Vehicle in Atopic Dermatitis?

Significantly more patients receiving ruxolitinib achieved investigator's global assessment treatment success, significant reduction of pruritus

By Dermsquared Editorial Team | | October 06, 2021

Use of Antihypertensive Drugs May Increase Risk for Psoriasis

Meta-analysis shows ACE inhibitors, ß-blockers, calcium-channel blockers, thiazide diuretics associated with increased risk for psoriasis

By Physician’s Briefing Staff | | October 06, 2021

Johnson & Johnson Seeks FDA Emergency Approval for Its Booster Shot

FDA advisory panel will review J&J data next week and vote on whether to recommend boosters

By Physician's Briefing Staff | | October 05, 2021

Study Confirms Virulence of SARS-CoV-2 Variants of Concern

Risks for hospitalization, ICU admission, death up for N501Y-positive variants; even more pronounced with delta variant

By Physician’s Briefing Staff | | October 05, 2021

Incidence of Keratinocyte Carcinoma Up From 2003 to 2017

Incidence rate higher for women younger than 55 years and for men aged 55 years and older; mortality higher for men

By Physician's Briefing Staff | | October 04, 2021

Scientists Share Nobel Prize for Discoveries That Changed Pain Research

The two scientists have helped answer one of the most profound questions about the human condition: How do we sense our environment?

By Physician’s Briefing Staff | | October 04, 2021

Chronic Spontaneous Urticaria Differs in Children, Adults

Incidence of angioedema, thyroid autoimmunity associated with chronic spontaneous urticaria lower for children than adults

By Physician’s Briefing Staff | | October 04, 2021

Is There a Laterality Preference for Lentigo Maligna, LM Melanoma?

Although no laterality preference found overall, neoplasms on head/neck show left-sided laterality; LM, LMM incidence highest on head/neck

By Dermsquared Editorial Team | | September 29, 2021

Recommendations Made for Treatment of Actinic Keratoses

Use of UV protection recommended; field treatment recommended with topical agents 5-FU and imiquimod

By Dermsquared Editorial Team | | September 29, 2021

Taxane-Containing Chemo Associated With Persistent Alopecia

However, many patients experience improvements in hair density with standard alopecia treatments

By Physician’s Briefing Staff | | September 29, 2021

FDA Takes New Action to Improve Quality, Efficacy of Sunscreens

Proposed changes include updates to safe active ingredients and broad spectrum requirements

By Physician’s Briefing Staff | | September 29, 2021

Live Attenuated Zoster Vaccine Safe for Patients Receiving TNF Inhibitors

No cases of varicella infection found; cumulative incidence of varicella infection or shingles was 0 percent

By Physician's Briefing Staff | | September 27, 2021

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026